APA

Hueber W., Sands B. E., Lewitzky S., Vandemeulebroecke M., Reinisch W., Higgins P. D. R., Wehkamp J., Feagan B. G., Yao M. D., Karczewski M., Karczewski J., Pezous N., Bek S., Bruin G., Mellgard B., Berger C., Londei M., Bertolino A. P., Tougas G. & Travis S. P. L. (20130114). Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. : Gut.

Chicago

Hueber Wolfgang, Sands Bruce E, Lewitzky Steve, Vandemeulebroecke Marc, Reinisch Walter, Higgins Peter D R, Wehkamp Jan, Feagan Brian G, Yao Michael D, Karczewski Marek, Karczewski Jacek, Pezous Nicole, Bek Stephan, Bruin Gerard, Mellgard Bjoern, Berger Claudia, Londei Marco, Bertolino Arthur P, Tougas Gervais and Travis Simon P L. 20130114. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. : Gut.

Harvard

Hueber W., Sands B. E., Lewitzky S., Vandemeulebroecke M., Reinisch W., Higgins P. D. R., Wehkamp J., Feagan B. G., Yao M. D., Karczewski M., Karczewski J., Pezous N., Bek S., Bruin G., Mellgard B., Berger C., Londei M., Bertolino A. P., Tougas G. and Travis S. P. L. (20130114). Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. : Gut.

MLA

Hueber Wolfgang, Sands Bruce E, Lewitzky Steve, Vandemeulebroecke Marc, Reinisch Walter, Higgins Peter D R, Wehkamp Jan, Feagan Brian G, Yao Michael D, Karczewski Marek, Karczewski Jacek, Pezous Nicole, Bek Stephan, Bruin Gerard, Mellgard Bjoern, Berger Claudia, Londei Marco, Bertolino Arthur P, Tougas Gervais and Travis Simon P L. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. : Gut. 20130114.